{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:02:56Z","timestamp":1776106976552,"version":"3.50.1"},"reference-count":42,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"unspecified","delay-in-days":97,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2025,9,11]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To identify different clusters of SLE patients in remission based on patient-reported outcomes (PROs) and clinical factors that predict cluster membership.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional monocentric study of adult consecutive SLE outpatients in stable clinical remission. Clinical and laboratory data were collected. At enrolment, each patient completed PROs. A hierarchical clustering analysis based on PROs exploring fatigue (Functional Assessment of Chronic Illness Therapy), disease impact (Lupus Impact Tracker), mental and physical health (mental component summary and physical component summary of the Short Form 36) was performed. Logistic regression assessed predictors of cluster membership, adjusting for demographic and clinical variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>195 SLE patients were enrolled. Two distinct clusters emerged: a \u2018low symptom burden (LSB)\u2019 cluster, including 81\/195 (41.5%) patients, and a \u2018high symptom burden (HSB)\u2019 cluster, including 114\/195 (58.5%) patients. The HSB was characterised by worse scores in all PROs compared with the LSB. The HSB cluster exhibited older age at diagnosis (33.23\u00b111.97 vs 27.75\u00b111.57; p=0.002), less frequent previous renal involvement (33.3% vs 65.4%; p&lt;0.001), more frequent previous neuropsychiatric lupus (17.2% vs 1.3%; p=0.001), more fibromyalgia (26.3% vs 5.3%; p=0.001) and ongoing glucocorticoid use (58.8% vs 37.0%; p=0.004). Fibromyalgia (OR 7.27, 95%\u2009CI 2.27 to 29.15, p=0.002) and glucocorticoid treatment (OR 3.05, 95%\u2009CI 1.43 to 6.77, p=0.005) were independently associated with higher likelihood of HSB membership; renal involvement was associated with LSB membership (OR 0.23, 95%\u2009CI 0.10 to 0.51, p\u22640.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among SLE patients in remission, two distinct health-related quality of life phenotypes can be identified: an HSB and an LSB. Fibromyalgia and glucocorticoid treatment emerged as independent predictors of HSB. These findings underline the need to optimise disease management and align treatment goals with patient priorities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/lupus-2025-001673","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:00:18Z","timestamp":1759824018000},"page":"e001673","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Predictors of patient-reported outcomes phenotypes in SLE during remission: a cluster analysis approach"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0657-485X","authenticated-orcid":false,"given":"Elena","family":"Elefante","sequence":"first","affiliation":[{"name":"Rheumatology Unit, University of Pisa, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francy","family":"Cruz-Sanabria","sequence":"additional","affiliation":[{"name":"Department of Developmental Neuroscience, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Foundation Stella Maris, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Gualtieri","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, University of Pisa, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Stagnaro","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, University of Pisa, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2161-2562","authenticated-orcid":false,"given":"Dina","family":"Zucchi","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, University of Pisa, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6407-6213","authenticated-orcid":false,"given":"Chiara","family":"Cardelli","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, University of Pisa, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viola","family":"Signorini","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, University of Pisa, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Carli","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, University of Pisa, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Ferro","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, University of Pisa, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Tani","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, University of Pisa, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Mosca","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, University of Pisa, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"2026010700555474000_12.2.e001673.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.11.001"},{"key":"2026010700555474000_12.2.e001673.2","doi-asserted-by":"publisher","DOI":"10.1080\/17402520600877760"},{"key":"2026010700555474000_12.2.e001673.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2013.07.009"},{"key":"2026010700555474000_12.2.e001673.4","first-page":"1706","article-title":"How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses?","volume":"32","author":"Jolly","year":"2005","journal-title":"J Rheumatol"},{"key":"2026010700555474000_12.2.e001673.5","doi-asserted-by":"publisher","DOI":"10.1002\/art.10512"},{"key":"2026010700555474000_12.2.e001673.6","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/rheumatology\/key349","article-title":"The relationship between remission and health-related quality of life in a cohort of SLE patients","volume":"58","author":"Tsang-A-Sjoe","year":"2019","journal-title":"Rheumatology (Sunnyvale)"},{"key":"2026010700555474000_12.2.e001673.7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210382"},{"key":"2026010700555474000_12.2.e001673.8","doi-asserted-by":"crossref","unstructured":"Ugarte-Gil MF , Gamboa-C\u00e1rdenas R , Re\u00e1tegui-Sokolova C , et al . Low Disease ActivityState\/Remission Predicts a Better Health-Related Quality of Life in Systemic LupusErythematosus Patients. Arthritis Care Res 2019. doi:10.1136\/lupus-2019-lsm.175","DOI":"10.1136\/lupus-2019-lsm.175"},{"key":"2026010700555474000_12.2.e001673.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102691"},{"key":"2026010700555474000_12.2.e001673.10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00393-019-00691-4","article-title":"Determinants of health-related quality of life in systemic lupus erythematosus: a monocentric, retrospective long-term observational study in Germany","volume":"78","author":"Vordenb\u00e4umen","year":"2019","journal-title":"Z Rheumatol"},{"key":"2026010700555474000_12.2.e001673.11","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1093\/rheumatology\/keac185","article-title":"Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus","volume":"61","author":"Emamikia","year":"2022","journal-title":"Rheumatology (Sunnyvale)"},{"key":"2026010700555474000_12.2.e001673.12","first-page":"243","article-title":"Disease activity, cumulative damage and quality of life in systematic lupus erythematosus: results of a cross-sectional study","volume":"6","author":"Hanly","year":"1997","journal-title":"Lupus (Los Angel)"},{"key":"2026010700555474000_12.2.e001673.13","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1093\/rheumatology\/keaa091","article-title":"Joint trajectories of disease activity, and physical and mental health-related quality of life in an inception lupus cohort","volume":"59","author":"Fung","year":"2020","journal-title":"Rheumatology (Sunnyvale)"},{"key":"2026010700555474000_12.2.e001673.14","first-page":"1606","article-title":"Factors influencing the health related quality of life in patients with systemic lupus erythematosus: long-term results (2001--2005) of patients in the German Lupus Erythematosus Self-Help Organization (LULA Study)","volume":"19","author":"Tamayo","year":"2010","journal-title":"Lupus (Los Angel)"},{"key":"2026010700555474000_12.2.e001673.15","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400928"},{"key":"2026010700555474000_12.2.e001673.16","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473"},{"key":"2026010700555474000_12.2.e001673.17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214819"},{"key":"2026010700555474000_12.2.e001673.18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209519"},{"key":"2026010700555474000_12.2.e001673.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2005.03.010"},{"key":"2026010700555474000_12.2.e001673.20","first-page":"373","article-title":"The Systemic Lupus International Collaborating Clinics\/American College of Rheumatology (SLICC\/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison","volume":"27","author":"Gladman","year":"2000","journal-title":"J Rheumatol"},{"key":"2026010700555474000_12.2.e001673.21","first-page":"1608","article-title":"Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus","volume":"24","author":"Stoll","year":"1997","journal-title":"J Rheumatol"},{"key":"2026010700555474000_12.2.e001673.22","first-page":"1953","article-title":"Systemic Lupus International Collaborating Clinics conference on assessment of lupus flare and quality of life measures in SLE. Systemic Lupus International Collaborating Clinics Group","volume":"23","author":"Gladman","year":"1996","journal-title":"J Rheumatol"},{"key":"2026010700555474000_12.2.e001673.23","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/acr.22349","article-title":"Development and Validation of the Lupus Impact Tracker: A Patient\u2010Completed Tool for Clinical Practice to Assess and Monitor the Impact of Systemic Lupus Erythematosus","volume":"66","author":"Jolly","year":"2014","journal-title":"Arthritis Care & Research"},{"key":"2026010700555474000_12.2.e001673.24","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100799"},{"key":"2026010700555474000_12.2.e001673.25","first-page":"635","article-title":"Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus","volume":"35","author":"Goligher","year":"2008","journal-title":"J Rheumatol"},{"key":"2026010700555474000_12.2.e001673.26","first-page":"1735","article-title":"Translation, cultural adaptation and validation of the Systemic Lupus Erythematosus Activity Questionnaire (SLAQ) in a cohort of Italian systemic lupus erythematosus patients","volume":"27","author":"Tani","year":"2018","journal-title":"Lupus (Los Angel)"},{"key":"2026010700555474000_12.2.e001673.27","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/acr.24546","article-title":"Systemic Lupus Erythematosus Symptom Clusters and Their Association With Patient\u2010Reported Outcomes and Treatment: Analysis of Real\u2010World Data","volume":"74","author":"Touma","year":"2022","journal-title":"Arthritis Care & Research"},{"key":"2026010700555474000_12.2.e001673.28","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-001006","article-title":"Outcome clusters and their stability over 1 year in patients with SLE: self-reported and performance-based cognitive function, disease activity, mood and health-related quality of life","volume":"11","author":"Gupta","year":"2024","journal-title":"Lupus Sci Med"},{"key":"2026010700555474000_12.2.e001673.29","first-page":"535","article-title":"Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis","volume":"37","author":"Margiotta","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"2026010700555474000_12.2.e001673.30","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-020-02334-5","article-title":"Articular involvement, steroid treatment and fibromyalgia are the main determinants of patient-physician discordance in systemic lupus erythematosus","volume":"22","author":"Elefante","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2026010700555474000_12.2.e001673.31","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/S2665-9913(19)30042-6","article-title":"Symptom-based stratification of patients with primary Sj\u00f6gren\u2019s syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials","volume":"1","author":"Tarn","year":"2019","journal-title":"The Lancet Rheumatology"},{"key":"2026010700555474000_12.2.e001673.32","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/acr.23794","article-title":"A Novel System to Categorize the Symptoms of Systemic Lupus Erythematosus","volume":"71","author":"Pisetsky","year":"2019","journal-title":"Arthritis Care & Research"},{"key":"2026010700555474000_12.2.e001673.33","first-page":"1584","article-title":"Fibromyalgia, mood disorders and chronic damage are the main determinants of worse quality of life in systemic lupus erythematosus patients: Results from a cross-sectional analysis","volume":"33","author":"Ceccarelli","year":"2024","journal-title":"Lupus (Los Angel)"},{"key":"2026010700555474000_12.2.e001673.34","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000793","article-title":"Systemic lupus erythematosus: state of the art on clinical practice guidelines","volume":"4","author":"Tamirou","year":"2018","journal-title":"RMD Open"},{"key":"2026010700555474000_12.2.e001673.35","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000469","article-title":"Living with systemic lupus erythematosus in 2020: a European patient survey","volume":"8","author":"Cornet","year":"2021","journal-title":"Lupus Sci Med"},{"key":"2026010700555474000_12.2.e001673.36","first-page":"501","article-title":"Discordance of patient and physician health status concerns in systemic lupus erythematosus","volume":"27","author":"Golder","year":"2018","journal-title":"Lupus (Los Angel)"},{"key":"2026010700555474000_12.2.e001673.37","first-page":"681","article-title":"Individuals living with lupus: findings from the LUPUS UK Members Survey 2014","volume":"27","author":"Morgan","year":"2018","journal-title":"Lupus (Los Angel)"},{"key":"2026010700555474000_12.2.e001673.38","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12093348","article-title":"Treat-to-Target in Systemic Lupus Erythematosus: Reality or Pipe Dream","volume":"12","author":"Zucchi","year":"2023","journal-title":"J Clin Med"},{"key":"2026010700555474000_12.2.e001673.39","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224762"},{"key":"2026010700555474000_12.2.e001673.40","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080822"},{"key":"2026010700555474000_12.2.e001673.41","first-page":"1038","article-title":"The relationship between neuropsychiatric, clinical, and laboratory variables and quality of life of Chinese patients with systemic lupus erythematosus","volume":"35","author":"Tam","year":"2008","journal-title":"J Rheumatol"},{"key":"2026010700555474000_12.2.e001673.42","first-page":"1252","article-title":"Neuropsychiatric symptoms in systemic lupus erythematosus: impact on quality of life","volume":"26","author":"Monahan","year":"2017","journal-title":"Lupus (Los Angel)"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2025-001673","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:56:47Z","timestamp":1767776207000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2025-001673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,10,6]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/lupus-2025-001673"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2025-001673","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}